Drug
Repaglinide And Metformin Combination
Repaglinide And Metformin Combination: highest development phase Phase 3, developed by Novo Nordisk. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| repaglinide and metformin combination tablet NCT00399711 | Phase 3 | Diabetes |
| repaglinide and metformin combination tablet NCT00959101 | Phase 1 | Diabetes |
Latest
No recent events.
Follow Repaglinide And Metformin Combination on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.